Drug Trial Radar · NCT00014989
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Last checked: Nov 20, 2026Latest source record: Jul 12, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,136
Actual
Start
Dec 1997
Primary completion
Feb 2007
Study completion Jun 2007
Sponsor
- Lead sponsor
- The George Washington University Biostatistics CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute of Neurological Disorders and Stroke (NINDS); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- First posted
- Apr 18, 2001
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Single group
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- Who can join
- Female only
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
As many more premature infants survive, the numbers of these infants with health problems increases. The rate of cerebral palsy (CP) in extremely premature infants is approximately 20%. Magnesium sulfate, the most commonly used drug in the US to stop premature labor, may prevent CP. This trial tests whether magnesium sulfate given to a woman in labor with a premature fetus (24 to 31 weeks out of 40) will reduce the rate of death or moderate to severe CP in the children at 2 years. The children receive ultrasounds of their brains as infants and attend three follow-up visits over two years to assess their health and development.
Conditions
- Cerebral Palsy
- Intraventricular Hemorrhage
- Periventricular Leukomalacia
- Pulmonary Edema
- Abruptio Placentae
Interventions
magnesium sulfateDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite outcome of death or moderate to severe cerebral palsy
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama
Birmingham, Alabama
Dept of OB/GYN, University of Miami
Miami, Florida
Northwestern University
Chicago, Illinois
Dept of OB/GYN, Hutzel Hospital
Detroit, Michigan
St. Luke's - Roosevelt Hospital
New York, New York
University of North Carolina
Chapel Hill, North Carolina
Forsyth Memorial Hospital, Wake Forest University School of Medicine
Winston-Salem, North Carolina
The University Hospital, University of Cincinnati
Cincinnati, Ohio
Case Western University
Cleveland, Ohio
Dept of OB/GYN, Ohio State University
Columbus, Ohio
MCP Hahnemann University
Philadelphia, Pennsylvania
Dept of OB/GYN Magee Womens Hospital
Pittsburgh, Pennsylvania
Women and Infants Hospital
Providence, Rhode Island
Dept of OB/GYN, Southwestern Medical Center, University of Texas
Dallas, Texas
University of Texas Medical Branch - Galveston
Galveston, Texas
University of Texas - Houston
Houston, Texas
University of Utah Medical Center
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.